ERBB2 and carcinoma: Non-special type (NST) carcinoma was the most common histologic sub-type (72.7%), with 90.0% of tumors being intermediate-high grade, 59.1% having high Ki67 (≥20%), and almost two-thirds having no HER2 expression (HER2 0, 65.9%).